SCHEMBL27672000

SCHEMBL27672000

COC(=O)N1CCCCC1c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 3/20 0.58
HSD11B1 P28845 1/20 0.55
PRMT5 O14744 4/20 0.54
WDR77 Q9BQA1 4/20 0.54
TMEM97 Q5BJF2 2/20 0.49
SIGMAR1 Q99720 2/20 0.49
EPHX2 P34913 2/20 0.49
ROCK2 O75116 1/20 0.48
PARP14 Q460N5 1/20 0.48
PARP10 Q53GL7 1/20 0.48
HSP90AA1 P07900 1/20 0.48
HSP90AB1 P08238 1/20 0.48
TRPC3 Q13507 1/20 0.47
TRPC6 Q9Y210 1/20 0.47
LMNA P02545 1/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12184218 1.00 RIPK1 (0.58) RIPK1HSD11B1PRMT5WDR77TMEM97
SCHEMBL10002512 0.95 RIPK1 (0.64) RIPK1HSD11B1PRMT5WDR77EPHX2
SCHEMBL26984487 0.85 TMEM97 (0.58) RIPK1HSD11B1PRMT5WDR77TMEM97
SCHEMBL24365127 0.85 FKBP1A (0.57) RIPK1HSD11B1PRMT5WDR77EPHX2
SCHEMBL17114341 0.85 RIPK1 (0.63) RIPK1HSD11B1PRMT5WDR77TMEM97
SCHEMBL24365782 0.85 RIPK1 (0.63) RIPK1HSD11B1PRMT5WDR77TMEM97
SCHEMBL7469150 0.85 RIPK1 (0.63) RIPK1HSD11B1PRMT5WDR77TMEM97
SCHEMBL24367619 0.85 FKBP1A (0.57) RIPK1HSD11B1PRMT5WDR77EPHX2
SCHEMBL8303313 0.85 TMEM97 (0.58) RIPK1HSD11B1PRMT5WDR77TMEM97
SCHEMBL12536841 0.85 RIPK1 (0.49) RIPK1HSD11B1PRMT5WDR77EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1898234-A Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases INCYTE CORP (US) 2007-01-17 CN disclosed